- Report
- January 2024
- 216 Pages
United States
From €3565EUR$3,750USD£2,995GBP
- Report
- March 2022
- 324 Pages
Global
From €9031EUR$9,500USD£7,587GBP
- Drug Pipelines
- March 2022
- 162 Pages
Global
From €5419EUR$5,700USD£4,552GBP
- Report
- November 2021
- 600 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Book
- June 2021
North America
- Book
- November 2019
North America
- Book
- September 2018
Asia Pacific
The Perioperative Pain Management market is a subset of the Analgesics market, which focuses on the management of pain during and after surgical procedures. Analgesics are drugs used to reduce or eliminate pain, and are typically administered before, during, and after surgery. Common analgesics used in perioperative pain management include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and local anesthetics. Opioids are used to provide short-term pain relief, while NSAIDs are used to reduce inflammation and local anesthetics are used to numb the area around the surgical site.
In addition to analgesics, other treatments used in perioperative pain management include nerve blocks, epidural injections, and transcutaneous electrical nerve stimulation (TENS). Nerve blocks are used to block pain signals from reaching the brain, while epidural injections are used to reduce inflammation and provide long-term pain relief. TENS is a non-invasive treatment that uses electrical stimulation to reduce pain.
Companies in the Perioperative Pain Management market include Pfizer, Merck, Johnson & Johnson, Novartis, and Sanofi. Show Less Read more